Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.98)
# 590
Out of 4,974 analysts
599
Total ratings
46.81%
Success rate
12.02%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $400.52 | +24.84% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $140.67 | +37.91% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.66 | +56.66% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $15.82 | +70.67% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.00 | +360.00% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $43.50 | +37.93% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $25.26 | +26.68% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $396.12 | +38.85% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $145.10 | -17.30% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.40 | +471.43% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $3.72 | -46.24% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $28.85 | +21.32% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $8.55 | +63.74% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $20.68 | +69.25% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.17 | +545.16% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $22.08 | +239.67% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $50.36 | +35.03% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $3.01 | +232.23% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $14.22 | +167.23% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $10.20 | +56.86% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $15.55 | +60.77% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $15.43 | +107.39% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.27 | +262.76% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $8.97 | +78.45% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $7.83 | +206.51% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.28 | +426.32% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $55.74 | -31.83% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.40 | +233.33% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $144.10 | +16.59% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.38 | +59.82% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.44 | +663.89% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.75 | +471.43% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $8.29 | +165.38% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $1.06 | +88.68% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.45 | +389.80% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.77 | +125.30% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.14 | +54.06% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.14 | +632.48% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.91 | +685.34% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $67.47 | +25.98% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $20.29 | +72.50% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $9.86 | +660.65% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $33.07 | +126.79% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.72 | +157.35% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.84 | +106.61% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $4.23 | +845.63% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.72 | +8,620.93% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $15.38 | +290.12% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.56 | +169.78% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.55 | +2,480.65% | 3 | Mar 16, 2022 |
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $400.52
Upside: +24.84%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $140.67
Upside: +37.91%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.66
Upside: +56.66%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $15.82
Upside: +70.67%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.00
Upside: +360.00%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $43.50
Upside: +37.93%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $25.26
Upside: +26.68%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $396.12
Upside: +38.85%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $145.10
Upside: -17.30%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.40
Upside: +471.43%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $3.72
Upside: -46.24%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $28.85
Upside: +21.32%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $8.55
Upside: +63.74%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $20.68
Upside: +69.25%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.17
Upside: +545.16%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $22.08
Upside: +239.67%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $50.36
Upside: +35.03%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $3.01
Upside: +232.23%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $14.22
Upside: +167.23%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $10.20
Upside: +56.86%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $15.55
Upside: +60.77%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $15.43
Upside: +107.39%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.27
Upside: +262.76%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $8.97
Upside: +78.45%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.83
Upside: +206.51%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.28
Upside: +426.32%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $55.74
Upside: -31.83%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.40
Upside: +233.33%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $144.10
Upside: +16.59%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.38
Upside: +59.82%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.44
Upside: +663.89%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.75
Upside: +471.43%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $8.29
Upside: +165.38%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $1.06
Upside: +88.68%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.45
Upside: +389.80%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.77
Upside: +125.30%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.14
Upside: +54.06%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.14
Upside: +632.48%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.91
Upside: +685.34%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $67.47
Upside: +25.98%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $20.29
Upside: +72.50%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $9.86
Upside: +660.65%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $33.07
Upside: +126.79%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.72
Upside: +157.35%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $4.84
Upside: +106.61%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $4.23
Upside: +845.63%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $1.72
Upside: +8,620.93%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $15.38
Upside: +290.12%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.56
Upside: +169.78%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.55
Upside: +2,480.65%